Aerolase

Aerolase develops advanced medical laser systems for dermatology and aesthetic care, serving practices that treat a wide range of skin types and concerns. Its platforms use proprietary ultra-short pulse technology, including 650-microsecond Nd:YAG and 300-microsecond Er:YAG systems, and are described as FDA-cleared for multiple indications. The company says its technology can be used across Fitzpatrick skin types I–VI, with no cooling setup or consumables required and typically no downtime.

Aerolase devices support treatments for acne, rosacea, hair removal, melasma and other pigmentation concerns, vascular lesions, scars, wrinkles, skin rejuvenation, and certain nail, autoimmune, ulcer, and wound conditions. The brand serves medical dermatology, medical aesthetics, plastic surgery, feminine wellness, and primary care specialties. It also provides before-and-after results, clinical resources, webinars, events, treatment calculators, and customer stories to help professionals explore its technology and applications. Through its clinic finder, Aerolase also helps patients locate providers offering its treatments. The company presents its systems as versatile tools designed to support patient comfort, clinical outcomes, and practice efficiency.